Published in Am J Pathol on September 01, 1990
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest (2001) 2.07
The role of liver-derived insulin-like growth factor-I. Endocr Rev (2009) 1.87
A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am J Pathol (2001) 1.30
Sickle cell disease and the kidney. Nat Clin Pract Nephrol (2008) 1.28
Resistance to glomerulosclerosis in B6 mice disappears after menopause. Am J Pathol (2003) 1.17
Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am J Pathol (1999) 1.12
Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med (1991) 1.09
Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model. Am J Pathol (2002) 1.04
A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J Anat (2005) 1.04
Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy. Diabetes Res Clin Pract (2006) 0.99
The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res (2007) 0.95
Plasma proteomic profiles of bovine growth hormone transgenic mice as they age. Transgenic Res (2011) 0.88
In vivo analysis of gene expression in long-lived mice lacking the pregnancy-associated plasma protein A (PappA) gene. Exp Gerontol (2010) 0.85
The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy. Curr Diabetes Rev (2011) 0.85
Identification of differentially expressed genes in the kidneys of growth hormone transgenic mice. Growth Horm IGF Res (2010) 0.83
Elevated systolic blood pressure in male GH transgenic mice is age dependent. Endocrinology (2013) 0.81
The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities. Kidney Res Clin Pract (2012) 0.76
Growth hormone (GH)-transgenic insulin-like growth factor 1 (IGF1)-deficient mice allow dissociation of excess GH and IGF1 effects on glomerular and tubular growth. Physiol Rep (2016) 0.76
Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial. Pediatr Nephrol (2015) 0.76
Ablation of hepatic production of the acid labile subunit in the bovine-GH transgenic mice; effects on organ and skeletal growth. Endocrinology (2017) 0.75
Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med (1989) 4.40
Protein blotting: principles and applications. Anal Biochem (1983) 4.27
Serum creatinine and renal function. Annu Rev Med (1988) 2.28
Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med (1989) 2.21
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest (1989) 1.73
Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology (1988) 1.72
The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest (1984) 1.72
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int (1983) 1.65
Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver. Cell (1984) 1.61
A thymocyte-activating factor derived from glomerular mesangial cells. J Immunol (1983) 1.59
Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol (1988) 1.55
The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes (1978) 1.52
Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int (1982) 1.48
Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology (1989) 1.25
Production of platelet-derived growth factorlike protein by rat mesangial cells in culture. J Clin Invest (1987) 1.24
Studies of progressive glomerular sclerosis in the rat. Am J Pathol (1986) 1.18
Evidence for the central role of glomerular growth promoters in the development of sclerosis. Semin Nephrol (1989) 1.11
Serial micropuncture analysis of single nephron function in subtotal renal ablation. Kidney Int (1988) 1.11
Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int (1987) 1.10
Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells. Endocrinology (1988) 1.07
The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Semin Nephrol (1989) 1.05
The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice. Clin Exp Immunol (1980) 1.03
Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology (1988) 1.03
Insulinlike growth factor-1 is a progression factor for human mesangial cells. Am J Pathol (1989) 1.02
Synthesis and release of insulinlike growth factor I by mesangial cells in culture. Am J Physiol (1988) 1.01
Use of gene transfer to increase animal growth. Cold Spring Harb Symp Quant Biol (1985) 1.01
Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest (1989) 0.95
Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest (1981) 0.93
Relationship of glomerular hypertrophy and sclerosis: studies in SV40 transgenic mice. Kidney Int (1990) 0.92
Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med (1989) 0.92
Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice. J Clin Invest (1988) 0.88
Mitogenic effects of growth hormone in cultured human fibroblasts. Evidence for action via local insulin-like growth factor I production. J Clin Invest (1988) 0.83
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (1986) 14.56
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
Germ-line transformation of mice. Annu Rev Genet (1986) 8.67
Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci U S A (1985) 7.32
Erythroid-specific expression of human beta-globin genes in transgenic mice. EMBO J (1985) 5.84
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Regulation of metallothionein--thymidine kinase fusion plasmids injected into mouse eggs. Nature (1982) 5.14
A 12-base-pair DNA motif that is repeated several times in metallothionein gene promoters confers metal regulation to a heterologous gene. Proc Natl Acad Sci U S A (1984) 5.08
A single erythroid-specific DNase I super-hypersensitive site activates high levels of human beta-globin gene expression in transgenic mice. Genes Dev (1989) 4.60
Differential regulation of metallothionein-thymidine kinase fusion genes in transgenic mice and their offspring. Cell (1982) 4.60
An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev (1987) 4.48
Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature (1982) 4.30
Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell (1981) 4.23
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell (1990) 4.05
Human gamma- to beta-globin gene switching in transgenic mice. Genes Dev (1990) 4.04
Metallothionein-human GH fusion genes stimulate growth of mice. Science (1983) 4.03
Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell (1987) 4.02
Two 3' sequences direct adult erythroid-specific expression of human beta-globin genes in transgenic mice. Proc Natl Acad Sci U S A (1987) 3.81
The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J Exp Med (1988) 3.80
Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell (1989) 3.60
Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell (1984) 3.56
Diversity of alpha-fetoprotein gene expression in mice is generated by a combination of separate enhancer elements. Science (1987) 3.44
Heterologous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci U S A (1991) 3.34
Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell (1991) 3.31
Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science (1990) 3.26
Replacement of diseased mouse liver by hepatic cell transplantation. Science (1994) 3.18
The effect of cells transferred into the mouse blastocyst on subsequent development. J Exp Med (1974) 3.17
Transplantation of testis germinal cells into mouse seminiferous tubules. Int J Dev Biol (1997) 3.10
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Factors influencing endothelial cell proliferation in vitro. J Cell Physiol (1978) 2.99
Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol (1986) 2.94
beta1- and alpha6-integrin are surface markers on mouse spermatogonial stem cells. Proc Natl Acad Sci U S A (1999) 2.91
The immune complex glomerulonephritis of bacterial endocarditis. Medicine (Baltimore) (1972) 2.82
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
Specific expression of an elastase-human growth hormone fusion gene in pancreatic acinar cells of transgenic mice. Nature (1985) 2.77
Tissue-specific expression of the rat pancreatic elastase I gene in transgenic mice. Cell (1984) 2.59
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest (1981) 2.50
A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science (1985) 2.47
Genetically haploid spermatids are phenotypically diploid. Nature (1989) 2.45
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Transplantation of male germ line stem cells restores fertility in infertile mice. Nat Med (2000) 2.37
The dopamine beta-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice. Neuron (1991) 2.37
Spermatid-specific expression of protamine 1 in transgenic mice. Proc Natl Acad Sci U S A (1987) 2.36
Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell (1988) 2.36
Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science (1987) 2.35
Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A (1994) 2.34
Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell (1987) 2.32
Transgenic mice. Cell (1985) 2.30
Spermatogonial stem cell enrichment by multiparameter selection of mouse testis cells. Proc Natl Acad Sci U S A (2000) 2.30
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
Production of transgenic rabbits, sheep and pigs by microinjection. Nature (1985) 2.26
High-level erythroid expression of human alpha-globin genes in transgenic mice. Proc Natl Acad Sci U S A (1989) 2.26
Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A (1987) 2.24
Pattern and kinetics of mouse donor spermatogonial stem cell colonization in recipient testes. Biol Reprod (1999) 2.21
Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance. Nature (1990) 2.20
Oncogene-induced liver neoplasia in transgenic mice. Oncogene (1989) 2.20
Structural-functional correlations in renal disease. II. The correlations. Hum Pathol (1970) 2.18
Glomerular cell culture. Lab Invest (1985) 2.16
The rat elastase I regulatory element is an enhancer that directs correct cell specificity and developmental onset of expression in transgenic mice. Mol Cell Biol (1987) 2.12
SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature (1985) 2.10
Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest (1983) 2.08
Human beta-globin locus control region: analysis of the 5' DNase I hypersensitive site HS 2 in transgenic mice. Proc Natl Acad Sci U S A (1991) 2.06
A novel MHC class II epitope expressed in thymic medulla but not cortex. Nature (1989) 2.06
Protamine 3'-untranslated sequences regulate temporal translational control and subcellular localization of growth hormone in spermatids of transgenic mice. Genes Dev (1989) 2.06
Induction of mouse metallothionein-I mRNA by bacterial endotoxin is independent of metals and glucocorticoid hormones. Proc Natl Acad Sci U S A (1984) 2.03
The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 2.01
Reconstitution of spermatogenesis from frozen spermatogonial stem cells. Nat Med (1996) 2.00
Expression of a microinjected immunoglobulin gene in the spleen of transgenic mice. Nature (1984) 2.00
Culture of mouse spermatogonial stem cells. Tissue Cell (1998) 1.98
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E. Nature (1989) 1.95
Developmental regulation of alpha-fetoprotein genes in transgenic mice. Mol Cell Biol (1985) 1.94
Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron (1993) 1.93
Allelic exclusion and control of endogenous immunoglobulin gene rearrangement in kappa transgenic mice. Nature (1985) 1.91
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol (1992) 1.83
Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell (1990) 1.83
Transgenic mice produced by retroviral transduction of male germ-line stem cells. Proc Natl Acad Sci U S A (2001) 1.83
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci U S A (1994) 1.82
Rat spermatogenesis in mouse testis. Nature (1996) 1.76
Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol Cell Biol (1993) 1.75
Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev (1988) 1.74
Germ cell transplantation from large domestic animals into mouse testes. Mol Reprod Dev (2000) 1.74
Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate Ia gene function. Cell (1987) 1.74
Remodeling of the postnatal mouse testis is accompanied by dramatic changes in stem cell number and niche accessibility. Proc Natl Acad Sci U S A (2001) 1.74
Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology (1988) 1.72
Transgenic mice with mu and kappa genes encoding antiphosphorylcholine antibodies. J Exp Med (1986) 1.72
Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci U S A (1991) 1.72
The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest (1984) 1.72
Transmission distortion and mosaicism in an unusual transgenic mouse pedigree. Cell (1984) 1.71
Human glomerular cells in vitro: isolation and characterization. Transplant Proc (1980) 1.69
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells. J Exp Med (1989) 1.67